H. Lee Moffitt Cancer Licenses Rosetta's Resolver | GenomeWeb
NEW YORK (GenomeWeb News) — The H. Lee Moffitt Cancer and Research Institute has licensed Rosetta Biosoftware’s Resolver software, Rosetta said today.
The Moffitt Institute, based in Tampa, Fla., will use the software to handle and analyze data generated by the Total Cancer Care program to help identify cancer biomarkers.
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.